Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FMK8B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,286
Award facts
- Contract value 100% obligated
- $17,285.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on January 28, 2026, for Enbrel 50 mg/ml SureClick auto-injectors valued at $17,285.51. The delivery order is structured as a firm fixed-price contract with a completion date of January 29, 2026, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
The pharmaceutical product being delivered—Enbrel, a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other autoimmune conditions—reflects the breadth of specialty medications supplied through the DLA contract vehicle. AmerisourceBergen's extensive portfolio with Defense Logistics Agency demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The company's significant presence in federal pharmaceutical supply underscores its critical role in supporting military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FMK8B?
SPE2DR26FMK8B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FMK8B worth?
The government has obligated $17,286 on SPE2DR26FMK8B.
Is contract SPE2DR26FMK8B an order under another contract?
Yes. SPE2DR26FMK8B is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK8B competed?
The extent of competition for SPE2DR26FMK8B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award